Financial report interval: 2025.12.31 - 2026.03.31
Overview: BETTA PHARMACEUTICALS(300558) the Revenue is 1.04 B (+13.33%);the EBIT is 296.33 M (+32.53%);the EPS is 0.56 (+133.3%).